XML 44 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 13 - Stock-based Compensation
12 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
13.
 
Stock-Based Compensation
 
Stock-Based Compensation Expense
 
Total stock-based compensation expense in the Company’s Consolidated Statements of Income related to the Company’s long-term incentive award plans was as follows (
in thousands
):
 
 
 
Years ended December 31,
 
 
 
2018
 
 
 
2017
 
 
 
2016
 
Cost of services-compensation
 
$
7,421
 
 
$
7,354
 
 
$
3,805
 
Selling, general and administrative
 
 
14,086
 
 
 
16,789
 
 
 
9,472
 
Total
 
$
21,507
 
 
$
24,143
 
 
$
13,277
 
 
The total tax benefits recognized on stock-based compensation for the years ended
December 31, 2018,
2017
and
2016
was
$9.1
million,
$4.0
million and
$4.1
million, respectively.
 
Stock Options
 
Stock-based compensation expense related to stock options was approximately
$9.6
million,
$10.3
million and
$6.9
million for the years ended
December 31, 2018,
2017
and
2016,
respectively.
   
Presented below is a summary of stock option activity for the year ended
December 31, 2018 (
in thousands except for weighted average exercise price and weighted average remaining contractual terms
):
 
 
 
 
Number of Options
 
 
 
Weighted

Average

Exercise

Price
 
 
 
Weighted

Average-

Remaining

Contractual

Terms
 
 
 
Aggregate-

Intrinsic

Value
 
Outstanding balance at December 31, 2017
 
 
5,554
 
 
$
17.35
 
 
 
 
 
 
 
 
 
Granted
 
 
1,010
 
 
 
19.58
 
 
 
 
 
 
 
 
 
Exercised
 
 
(2,017
)
 
 
19.14
 
 
 
 
 
 
 
 
 
Forfeitures
 
 
(114
)
 
 
17.74
 
 
 
 
 
 
 
 
 
Expired
 
 
(31
)
 
 
22.34
 
 
 
 
 
 
 
 
 
Outstanding balance at December 31, 2018
 
 
4,402
 
 
 
17.07
 
 
 
5.80
 
 
$
48,339
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expected to vest at December 31, 2018
 
 
1,481
 
 
$
18.60
 
 
 
8.22
 
 
$
14,119
 
Exercisable at December 31, 2018
 
 
2,370
 
 
$
15.87
 
 
 
3.83
 
 
$
29,068
 
 
As of
December 31, 2018
and
2017,
the Company had
1,999,069
and
2,372,682,
respectively, in unvested options with a weighted-average-grant-date fair value of
$7.27
and
$6.39,
respectively. The weighted-average-grant-date fair value per share of the stock options granted during the years ended
December 31, 2018,
2017
and
2016
was
$7.52,
$7.66
and
$5.55,
respectively. The weighted-average-grant-date fair value per share of stock options vested during the year ended
December 31, 2018
was
$6.18.
The weighted-average-grant-date fair value per share of the stock options forfeited during the years ended
December 31, 2018,
2017
and
2016
was
$6.86,
$5.24
and
$6.26,
respectively.
 
HMS estimated the fair value of each stock option grant on the date of grant using a Black-Scholes option pricing model. Weighted–average assumptions are set forth in the following table:
 
 
 
Year ended December 31,
 
 
 
2018
 
 
 
2017
 
 
 
2016
 
Expected dividend yield
 
 
-
 
 
 
-
 
 
 
-
 
Risk-free interest rate
 
 
2.7
%
 
 
1.8
%
 
 
1.2
%
Expected volatility
 
 
42.4
%
 
 
44.2
%
 
 
44.0
%
Expected life (years)
 
 
6.0
 
 
 
5.0
 
 
 
4.9
 
 
HMS estimated the fair value of
2017
and
2016
market condition option grants on the date of grant using a Monte-Carlo simulation model. There were
no
market condition awards granted in
2018.
Assumptions are set forth in the following table:
 
 
 
Year ended December 31,
 
 
 
2018
 
 
 
2017
 
 
 
2016
 
Expected dividend yield
 
 
-
 
 
 
-
 
 
 
-
 
Risk-free interest rate
 
 
-
 
 
 
2.2
%
 
 
1.6
%
Expected volatility
 
 
-
 
 
 
52.5
%
 
 
40.5
%
Expected life (years)
 
 
-
 
 
 
6.5
 
 
 
4.9
 
 
During the years ended
December 31, 2018,
2017
and
2016,
the Company issued
2,017,442,
172,326
and
510,512
shares, respectively, of the Company’s common stock upon the exercise of outstanding stock options and received proceeds of
$38.3
million,
$2.7
million and
$2.9
million, respectively. The total intrinsic value of stock options exercised during the years ended
December 31, 2018,
2017
and
2016
was
$27.6
million,
$0.5
million and
$6.3
million, respectively.
 
As of
December 31, 2018,
there was approximately
$5.5
million of total unrecognized compensation cost related to stock options outstanding, which is expected to be recognized over a weighted average period of
0.9
years.
 
Restricted Stock Units
 
Stock-based compensation expense related to restricted stock units was
$11.9
million,
$13.8
million and
$6.4
million for the years ended
December 31, 2018,
2017
and
2016,
respectively.
 
Presented below is a summary of restricted stock units activity for the year ended
December 31, 2018 (
in thousands, except for weighted average grant date fair value per unit
):
 
 
 
 
Number of

Units
 
Weighted Average

Grant Date Fair

Value per Unit
Outstanding balance at December 31, 2017
 
 
1,346
 
 
$
17.65
 
Granted
 
 
766
 
 
 
16.80
 
Vesting of restricted stock units, net of units withheld for taxes
 
 
(371
)
 
 
17.06
 
Units withheld for taxes
 
 
(163
)
 
 
17.06
 
Forfeitures
 
 
(90
)
 
 
17.31
 
Outstanding balance at December 31, 2018
 
 
1,488
 
 
$
17.60
 
 
 
As of
December 31, 2018,
1,259,003
restricted stock units remained unvested and there was approximately
$9.2
million of unrecognized compensation cost related to restricted stock units, which is expected to be recognized over a weighted average vesting period of
0.87
years. During the years ended
December 31, 2018,
2017
and
2016,
the Company’s vested restricted stock units had a fair value
$9.9
million,
$9.5
million, and
$6.8
million, respectively. The weighted average grant date fair value per share of the restricted stock units vested during the years ended
December 31, 2018,
2017
and
2016
was
$17.06,
$15.39
and
$18.64,
respectively. The weighted average grant date fair value per share of the restricted stock units forfeited during the years ended
December 31, 2018,
2017
and
2016
was
$17.31,
$15.37
and
$16.95,
respectively.